Jones Financial Companies
JANX icon

Jones Financial Companies’s Janux Therapeutics JANX Stock Holding History

Jones Financial Companies’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Buy
10,371
+6,145
+145% +$84.3K ﹤0.01% 2541
2025
Q4 		$58.3K Buy
4,226
+4,138
+4,702% +$97.3K ﹤0.01% 2448
2025
Q3 		$2.04K Hold
88
– – ﹤0.01% 3684
2025
Q2 		$2.04K Sell
88
-19
-18% -$501 ﹤0.01% 3463
2025
Q1 		$3.11K Buy
+107
New +$4.03K ﹤0.01% 3125

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jones Financial Companies's JANX Position: Q1 2026 in Review

Jones Financial Companies increased its Janux Therapeutics (JANX) stake by 145% in Q1 2026, buying an estimated $84.3K and bringing the position to 10,371 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

Jones Financial Companies first reported a position in JANX in Q1 2025 and has held it in 5 quarters since. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Jones Financial Companies held 10,371 shares of Janux Therapeutics worth $137K as of Q1 2026.
  • Jones Financial Companies bought 6,145 Janux Therapeutics shares in Q1 2026, an estimated $84.3K.
  • Janux Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2541 holding.
  • Jones Financial Companies first reported a position in Janux Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.